SHARON DUDLEY-BROWN: Open Payments
NPI 1427057272 · BEL AIR, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,993 in 61 payments from 10 companies in 2025. Trend: 2023 $14,308 · 2024 $18,123 · 2025 $8,993
Consulting: $3,781Speaker / faculty: $3,500Food & beverage: $1,587Travel & lodging: $125
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $5,029 |
| Janssen Biotech, Inc. | 12 | $2,106 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $1,543 |
| PFIZER INC. | 5 | $84 |
| Lilly USA, LLC | 2 | $66 |
| Janssen Scientific Affairs, LLC | 1 | $40 |
| Phathom Pharmaceuticals, Inc. | 2 | $40 |
| Celltrion USA Inc. | 2 | $34 |
| GENZYME CORPORATION | 1 | $26 |
| Intercept Pharmaceuticals, Inc. | 1 | $25 |
Products named: TREMFYA, RINVOQ, ENTYVIO, SKYRIZI, OMVOH, VELSIPITY, VOQUEZNA, VEGZELMA.
Industry payments across MD — which companies pay providers there.
